Category: Treatment


Introducing Clinical Trial Navigator: Start Searching Today

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 5 December 2017 In Allies & Partnerships, News, Science, Treatment

At MRA, we know that advancing science is our best bet in the fight against melanoma. More than 87,000 people in the US will be diagnosed with melanoma this year, and with these numbers on the rise, researchers are working harder than ever to find new and better treatment options. In fact, there are over 300 clinical trials happening in melanoma right now.

Read More


‘Practice Changing’ Results Hint at New Adjuvant Therapy Treatment Options

30 September 2017 In Treatment

Adjuvant treatment is used in addition to tumor removal e.g. via surgery or radiotherapy to help delay or prevent the recurrence of melanoma. It is often recommended for high-risk melanoma (defined as melanoma deeper or thicker than 4mm thick at the primary site or involves nearby lymph nodes). Approved adjuvant therapies in melanoma include interferon and, more recently, ipilimumab. But neither of these approaches is wholly satisfying since relatively few patients appear to benefit and side-effects are a major factor.

Read More


A Mother’s Perspective: New Options for Pediatric Melanoma

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 6 September 2017 In Melanoma Stories, News, Treatment

When Cheryl Trocke’s nine-year old son Graham was diagnosed with melanoma four years ago, she quickly learned that when it comes to kids, there were no great treatment options and that care can vary greatly based on where your child is treated. After surgically removing the primary tumor, Graham’s doctors suggested a treatment plan of ‘wait and see.’

Read More


Doubling Down: Brandon Barniea Bets Big on Combination Therapy

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 6 September 2017 In Melanoma Stories, Treatment

Brandon Barniea didn’t believe he needed to visit doctors. The athletic 35-year-old had always been healthy – even when his wife and two kids were sick at home with the flu, he would miraculously avoid falling ill. So, when he found what felt like “beads” in his neck, reality came crashing in; following a biopsy, he was diagnosed first with stage III melanoma in August 2015 and later that year it progressed to stage IV.

Read More


L’Oréal Paris USA-MRA Team Scientists shed light on how melanoma spreads

By Kristen Mueller, PhD | 29 August 2017 In Allies & Partnerships, Science, Treatment

MRA is extremely proud of the 289 investigators we have funded over the last decade and the exciting advances they have made toward ending suffering and death due to melanoma. While we can never highlight all of them at one time, we’re excited in this blog to highlight the work of the L’Oreal Paris USA sponsored MRA Team award.

Read More


Why so much excitement about CAR-T cells?

By Kristen Mueller, PhD | 18 July 2017 In News, Science, Treatment

July 12, 2017, marked a historic day for medicine and for the US Food and Drug Administration (FDA) when an expert advisory committee to the FDA unanimously endorsed the first ever genetically engineered, cell-based therapy for use in patients.

Read More


Melanoma Treatments: Breakthroughs for Multiple Cancers — for Real and Right Now

10 July 2017 In Science, Treatment

While 2014 and 2015 offered a whirlwind of good news related to new melanoma treatments from immune to targeted therapy, since then, it’s been a bit quieter in melanoma. Although there has been exceptional news in regard to other cancers. Why is that, and what are the latest breakthroughs?

Read More


Invincible, Until You’re Not

By Pamela Goldsmith, MRA Director of Communications | 6 June 2017 In Melanoma Stories, Prevention, Treatment

Self described, lifetime sun worshiper and tanning bed devotee, 24-year old native Texan Ali Young was barely daunted the first time she was diagnosed with deadly skin cancer at the age of 18. Matter of fact, she recalls heading to the tanning bed the very day after her biopsy.

Read More


The Genetics of Melanoma Goes Deep

By Kristen Mueller, PhD | 6 June 2017 In News, Science, Treatment

Due to the rapid advancements in DNA sequencing technologies, our understanding of the underlying genetic causes of cancer has increased substantially in the past decade. In the case of melanoma, researchers have now characterized in great detail the genetic changes that occur within tumor cells in melanoma of the skin, leading to the FDA approval of drugs targeting mutations in BRAF and MEK.

Read More


What Gut Bacteria Tell Us About Treating Melanoma and Other Cancers

By Pamela Goldsmith, MRA Director of Communications | 3 April 2017 In News, Science, Treatment

Despite success in the use of immunotherapy to treat cancer by harnessing the body’s immune system to fight it, a major difficulty continues to be the range of responses to treatment among patients. It’s why researchers are exploring why some cancer patients exhibit astounding results with little side effects while others receive no benefits to the treatment and/or experience severe side effects.

Read More


Login

×